Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer

Background and objectives: Multi-gene signature can be used as prognostic indicator in many types of cancer, but the association with early-relapse in patients with stage I-III clear cell and papillary renal cell cancer (RCC) is unknown. We aim to establish a mRNAs signature for improving prediction...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Da-Long, Dai, Wei-Xing, Huang, Yong-Qiang, Yu, Lei-Jun, Wu, Jun-Long, Shi, Guo-Hai, Zhang, Hai-Liang, Zhu, Yao, Dai, Bo, Ye, Ding-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959077/
https://www.ncbi.nlm.nih.gov/pubmed/31956346
http://dx.doi.org/10.7150/jca.38274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959077/
https://www.ncbi.nlm.nih.gov/pubmed/31956346
http://dx.doi.org/10.7150/jca.38274

Ejemplares similares